Ageing is associated with significant immunological changes that can influence both the progression of the disease and the ...

GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) ...

Want to truly engage and educate HCPs? Learn to avoid costly mistakes and be at the forefront of learning by creating a ...

Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy ...

Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions.

Boehringer Ingelheim and Cue Biopharma have announced a partnership worth $357m to develop and commercialise Cue’s ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has been approved by the European Commission (EC). The ...

This shift is transforming the dynamic between patients and healthcare professionals (HCPs) and in turn, the decision-making ...

Merck & Co – known as MSD outside of the US and Canada – and Cyprumed have entered into a partnership aimed at developing ...

Exclusion from healthcare decisions can result from various barriers, including language, health literacy, cultural factors ...

Amgen has shared positive results from a late-stage study of its immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been approved by the US Food and Drug ...